Marius Braun

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 438 citations

Fibrosis, Hepatology, Liver Physiology +9

Metabolic syndrome in liver transplant recipients

Ido Laish, Marius Braun, Eytan Mor et al. · Liver Transplantation · 2010 · 257 citations · Full text

A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease

Manuel Romero‐Gómez, Eric Lawitz, R. Ravi Shankar et al. · Journal of Hepatology · 2023 · 163 citations · Full text

Lusutrombopag for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures (L‐PLUS 2)

Markus Peck‐Radosavljevic, Krzysztof Simon, A. Iacobellis et al. · Hepatology · 2019 · 141 citations · Full text